Delivery Order SPE2DR25D1100-SPE2DR26FCL3F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,167.21 to AmerisourceBergen Drug Corp for the supply of Prograf 0.5 mg capsules (100 count) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $27,638.41 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) with a completion date of August 25, 2025. This is a firm fixed-price delivery order under a non-set-aside competition, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $106,966.00 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units). This firm fixed-price, competitively awarded contract, with no set-aside designation, was finalized on September 22, 2025, with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,663.57 on October 20, 2025, for the supply of Prograf 0.5 mg capsules (100-count units). This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 21, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $36,127.45 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) with a ceiling value of $1,303.59. This firm fixed-price delivery order, awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a direct fulfillment from AmerisourceBergen's existing contract vehicle. The award was made through open competition with no set-aside designation, and performance will take place at the...
- The Defense Logistics Agency awarded a $1,738.12 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Prograf 1 mg capsules (100-count units). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $41,735.37 to AmerisourceBergen Drug Corp for the supply of Prograf 5 mg capsules (100 count units) under a firm fixed price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a competitively awarded transaction for a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,999.03 to AmerisourceBergen Drug Corp for 100 capsules of Prograf 0.5 mg on October 29, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 30, 2025. This delivery order is a child...
- The Defense Logistics Agency awarded a $18,879.92 delivery order to AmerisourceBergen Drug Corp for Prograf 1 mg capsules (100-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and autoimmune disease management, representing part...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCL3FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,223.59 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) under a firm fixed price contract. The contract was competitively awarded without any set-aside designation and is scheduled for completion by October 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical commodities to support military healthcare systems and federal medical procurement needs. Prograf is an immunosuppressive medication used in transplant patients, reflecting the company's role in providing specialized pharmaceutical products across multiple therapeutic domains to federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 10/29/25 |